Literature DB >> 15139835

Octreotide treatment for sulfonylurea-induced hypoglycaemia.

Bronwyn A L Crawford, Channa Perera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15139835     DOI： 10.5694/j.1326-5377.2004.tb06064.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  4 in total

Review 1.  Octreotide's role in the management of sulfonylurea-induced hypoglycemia.

Authors:  Patrick P Dougherty; Wendy Klein-Schwartz
Journal:  J Med Toxicol       Date:  2010-06

2.  Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide.

Authors:  Paul I Pelavin; Erika Abramson; Steven Pon; Maria G Vogiatzi
Journal:  J Pediatr Endocrinol Metab       Date:  2009-02       Impact factor: 1.634

Review 3.  Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.

Authors:  Philippe E R Lheureux; Soheil Zahir; Andrea Penaloza; Mireille Gris
Journal:  Crit Care       Date:  2005-09-07       Impact factor: 9.097

Review 4.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.